CORR Insights®: Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity?
暂无分享,去创建一个
[1] K. Chouliaras,et al. Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity? , 2020, Clinical orthopaedics and related research.
[2] J. Wunder,et al. Risk factors for postoperative wound complications after extremity soft tissue sarcoma resection: A systematic review and meta-analyses. , 2019, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[3] J. Blay,et al. Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses , 2019, BMC Cancer.
[4] R. Castelein,et al. Soft tissue sarcoma of the hand: Is unplanned excision a problem? , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[5] Peter Hohenberger,et al. Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group , 2019, Cancers.
[6] A. D. Dei Tos,et al. Soft tissue sarcoma in Italy: From epidemiological data to clinical networking to improve patient care and outcomes. , 2019, Cancer epidemiology.
[7] H. V. van Boven,et al. Time dependent dynamics of wound complications after preoperative radiotherapy in Extremity Soft Tissue Sarcomas. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[8] E. Bastiaannet,et al. Identification of predictors for wound complications following preoperative or postoperative radiotherapy in extremity soft tissue sarcoma. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[9] K. Delman,et al. The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas , 2017, Annals of Surgical Oncology.
[10] J. Blay,et al. Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial. , 2016, The Lancet. Oncology.
[11] D. Kirsch,et al. Radiation Therapy for Soft Tissue Sarcoma: Indications and Controversies for Neoadjuvant Therapy, Adjuvant Therapy, Intraoperative Radiation Therapy, and Brachytherapy. , 2016, Surgical oncology clinics of North America.
[12] A. Davis,et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial , 2002, The Lancet.